JP2012531896A - ヒト化非ヒト哺乳動物を製造する方法 - Google Patents

ヒト化非ヒト哺乳動物を製造する方法 Download PDF

Info

Publication number
JP2012531896A
JP2012531896A JP2012517837A JP2012517837A JP2012531896A JP 2012531896 A JP2012531896 A JP 2012531896A JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012531896 A JP2012531896 A JP 2012531896A
Authority
JP
Japan
Prior art keywords
human
cells
mammal
cytokines
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012517837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012531896A5 (cg-RX-API-DMAC7.html
Inventor
チェン,チンフェン
チェン,チエンチュ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2012531896A publication Critical patent/JP2012531896A/ja
Publication of JP2012531896A5 publication Critical patent/JP2012531896A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0381—Animal model for diseases of the hematopoietic system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2012517837A 2009-06-29 2010-06-28 ヒト化非ヒト哺乳動物を製造する方法 Pending JP2012531896A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22143809P 2009-06-29 2009-06-29
US61/221,438 2009-06-29
PCT/US2010/040260 WO2011002727A1 (en) 2009-06-29 2010-06-28 Methods of producing humanized non-human mammals

Publications (2)

Publication Number Publication Date
JP2012531896A true JP2012531896A (ja) 2012-12-13
JP2012531896A5 JP2012531896A5 (cg-RX-API-DMAC7.html) 2013-08-15

Family

ID=43411395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012517837A Pending JP2012531896A (ja) 2009-06-29 2010-06-28 ヒト化非ヒト哺乳動物を製造する方法

Country Status (6)

Country Link
US (1) US20120157667A1 (cg-RX-API-DMAC7.html)
EP (1) EP2449094A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012531896A (cg-RX-API-DMAC7.html)
CN (1) CN102725400A (cg-RX-API-DMAC7.html)
SG (2) SG10201403703XA (cg-RX-API-DMAC7.html)
WO (1) WO2011002727A1 (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017515471A (ja) * 2014-05-19 2017-06-15 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
WO2019098362A1 (ja) * 2017-11-17 2019-05-23 国立大学法人筑波大学 非ヒト動物及びその製造方法
JP2020168024A (ja) * 2012-09-07 2020-10-15 イエール ユニバーシティ 遺伝学的に修飾された非ヒト動物およびその使用法
JP2022520237A (ja) * 2019-02-13 2022-03-29 ザ ジャクソン ラボラトリー 自然免疫機能を支持するトランスジェニックマウスモデル

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4502152A3 (en) 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
PT4233537T (pt) 2011-02-15 2025-09-08 Regeneron Pharma Ratinhos humanizados para m-csf e utilizações dos mesmos
WO2013086019A1 (en) * 2011-12-06 2013-06-13 Massachusetts Institute Of Technology Use of humanized mice to determine toxicity
CN103387955B (zh) * 2012-05-10 2015-04-29 上海南方模式生物科技发展有限公司 非人哺乳动物b淋巴细胞缺陷动物模型的制备方法及其用途
WO2014039733A1 (en) * 2012-09-05 2014-03-13 University Of Southern California Methods and compositions for detecting, imaging, and treating small cell lung cancer utilizing post-translationally modified residues and higher molecular weight antigenic complexes in proteins
DK4389764T3 (da) * 2012-11-05 2026-04-13 Regeneron Pharma Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf
WO2014121840A1 (en) * 2013-02-07 2014-08-14 Medizinische Hochschule Hannover Induced dendritic cells and uses thereof
WO2014196929A1 (en) * 2013-06-05 2014-12-11 Agency For Science, Technology And Research A humanized mouse model for study of bona fide hepatitis virus infection and use thereof
NO2785538T3 (cg-RX-API-DMAC7.html) * 2014-05-07 2018-08-04
ES2950399T3 (es) 2015-04-13 2023-10-09 Regeneron Pharma Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos
JP6654001B2 (ja) * 2015-05-27 2020-02-26 公益財団法人実験動物中央研究所 ヒトil−15分泌免疫不全マウス
EP3383173B1 (en) * 2015-11-30 2020-11-25 H. Hoffnabb-La Roche Ag Generation of human macrophages in immunodeficient mice
CN111304248B (zh) 2018-12-25 2021-08-24 百奥赛图江苏基因生物技术有限公司 人源化细胞因子il15基因改造非人动物的构建方法及应用
CN111172190B (zh) * 2018-12-25 2021-07-30 百奥赛图江苏基因生物技术有限公司 人源化细胞因子csf2基因改造非人动物的构建方法及应用
WO2020157997A1 (ja) * 2019-01-28 2020-08-06 公益財団法人実験動物中央研究所 ヒトil-34を有する非ヒト動物及びその使用
US20220192166A1 (en) * 2019-03-28 2022-06-23 Central Institute For Experimental Animals Immunodeficient rodent
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术(上海)有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
US20230340524A1 (en) * 2020-07-08 2023-10-26 The Jackson Laboratory Transgenic mouse models supporting human innate immune function
CN112042597B (zh) * 2020-07-22 2022-04-29 南京普恩瑞生物科技有限公司 一种双人源化肿瘤异种移植模型的构建方法
CN114853871B (zh) * 2021-04-20 2024-04-05 百奥赛图(北京)医药科技股份有限公司 Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用
CN117070524A (zh) * 2022-08-15 2023-11-17 江苏集萃药康生物科技股份有限公司 一种白介素人源化的非人动物的制备方法及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0231632A (ja) * 1987-12-23 1990-02-01 Univ Leland Stanford Jr キメラ性非ヒト動物及びそれらの使用
JPH09506626A (ja) * 1993-12-17 1997-06-30 システミクス・インコーポレイテッド 非自己造血細胞移植片の生存延長のためのマクロファージ枯渇剤の使用および動物モデル検定系
US6060643A (en) * 1995-08-04 2000-05-09 Emory University Mouse model with human immune system
JP2006501177A (ja) * 2002-06-24 2006-01-12 ジェンザイム・コーポレイション 遺伝子治療薬を送達する方法
WO2007120811A2 (en) * 2006-04-14 2007-10-25 Advanced Cell Technology, Inc. Hemangio-colony forming cells
JP2007530121A (ja) * 2004-03-25 2007-11-01 ハイドロダイナミック・ジーン・デリヴァリー・リミテッド 遺伝子治療

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639939A (en) * 1987-12-23 1997-06-17 The Board Of Trustees For The Leland Stanford Junior University Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US20070021364A1 (en) * 1995-12-13 2007-01-25 Hans Herweijer Methods for genetic immunization
WO1999061589A2 (en) * 1998-05-28 1999-12-02 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
AU4323599A (en) * 1998-05-29 1999-12-13 Instituto Superiore Di Sanita Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
US8252587B2 (en) * 2004-10-25 2012-08-28 Celerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
CA2680613A1 (en) * 2007-03-13 2008-09-18 National Jewish Medical And Research Center Methods for generation of antibodies
CA2636876A1 (en) * 2008-02-25 2009-08-25 Gestion Univalor Inc. Methods and kits for expanding hematopoietic stem cells
WO2010115115A1 (en) * 2009-04-03 2010-10-07 Inserm ( Institut National De La Sante Et De La Recherche) Dendritic cell-boosted humanized immune system mice
SG10201403707QA (en) * 2009-06-29 2014-10-30 Ilya B Leskov Non-human mammal model of human hematopoietic cancer
EP4502152A3 (en) * 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0231632A (ja) * 1987-12-23 1990-02-01 Univ Leland Stanford Jr キメラ性非ヒト動物及びそれらの使用
JPH09506626A (ja) * 1993-12-17 1997-06-30 システミクス・インコーポレイテッド 非自己造血細胞移植片の生存延長のためのマクロファージ枯渇剤の使用および動物モデル検定系
US6060643A (en) * 1995-08-04 2000-05-09 Emory University Mouse model with human immune system
JP2006501177A (ja) * 2002-06-24 2006-01-12 ジェンザイム・コーポレイション 遺伝子治療薬を送達する方法
JP2007530121A (ja) * 2004-03-25 2007-11-01 ハイドロダイナミック・ジーン・デリヴァリー・リミテッド 遺伝子治療
WO2007120811A2 (en) * 2006-04-14 2007-10-25 Advanced Cell Technology, Inc. Hemangio-colony forming cells

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN6014045280; 50th ASH Annual Meeting and Expression, Online Program and Abstracts , 2008 *
JPN6014046581; Curr. Top. Microbiol. Immunol. Vol. 324, 2008, P. 109-124 *
JPN6015045226; J. Gene Med. Vol. 8, 2006, pp. 1018-1026 *
JPN6015045227; Mol. Ther. Vol. 15, No. 12, 2007, pp. 2063-2069 *
JPN7014003151; J. Exp. Med. Vol. 182, 1995, P. 2037-2043 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020168024A (ja) * 2012-09-07 2020-10-15 イエール ユニバーシティ 遺伝学的に修飾された非ヒト動物およびその使用法
JP7066785B2 (ja) 2012-09-07 2022-05-13 イエール ユニバーシティ 遺伝学的に修飾された非ヒト動物およびその使用法
JP2024009054A (ja) * 2014-05-19 2024-01-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
JP2022109288A (ja) * 2014-05-19 2022-07-27 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
JP7385703B2 (ja) 2014-05-19 2023-11-22 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
JP2017515471A (ja) * 2014-05-19 2017-06-15 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
JP7620688B2 (ja) 2014-05-19 2025-01-23 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
JP2025061185A (ja) * 2014-05-19 2025-04-10 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
JP7833059B2 (ja) 2014-05-19 2026-03-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトepoを発現する遺伝子改変された非ヒト動物
JPWO2019098362A1 (ja) * 2017-11-17 2021-01-14 国立大学法人 筑波大学 非ヒト動物及びその製造方法
WO2019098362A1 (ja) * 2017-11-17 2019-05-23 国立大学法人筑波大学 非ヒト動物及びその製造方法
JP7136474B2 (ja) 2017-11-17 2022-09-13 国立大学法人 筑波大学 非ヒト動物及びその製造方法
JP2022520237A (ja) * 2019-02-13 2022-03-29 ザ ジャクソン ラボラトリー 自然免疫機能を支持するトランスジェニックマウスモデル
JP2024169631A (ja) * 2019-02-13 2024-12-05 ザ ジャクソン ラボラトリー 自然免疫機能を支持するトランスジェニックマウスモデル
US12378574B2 (en) 2019-02-13 2025-08-05 The Jackson Laboratory Transgenic mouse models supporting innate immune function

Also Published As

Publication number Publication date
WO2011002727A1 (en) 2011-01-06
EP2449094A4 (en) 2013-07-10
EP2449094A1 (en) 2012-05-09
SG10201403703XA (en) 2014-10-30
WO2011002727A9 (en) 2011-02-24
US20120157667A1 (en) 2012-06-21
SG176118A1 (en) 2011-12-29
CN102725400A (zh) 2012-10-10

Similar Documents

Publication Publication Date Title
US20120157667A1 (en) Methods Of Producing Humanized Non-Human Mammals
JP7050105B2 (ja) 遺伝子改変されたマウスおよび移植方法
Garcia et al. Humanized mice: current states and perspectives
JP3753321B2 (ja) 異種細胞の生着、分化および増殖に適したマウスの作出方法、該方法により作出されたマウスならびにそのマウスの用途
US10575505B2 (en) Human IL-15-secreting immunodeficient mouse
US9439404B2 (en) Boosting human dendritic cell development, homeostasis and function in xenografted immunodeficient mice
WO2022138928A1 (ja) ヒト樹状細胞が分化するヒトflt3lトランスジェニックげっ歯類動物
CN101179931B (zh) 人类免疫系统的动物模型的产生方法及用途
AU2015255177B2 (en) Genetically modified mice and engraftment
AU2013202676B2 (en) Genetically modified mice and engraftment
HK40079372A (en) Genetically modified mice and engraftment
HK40079372B (en) Genetically modified mice and engraftment
Roncarolo et al. Human hematopoiesis in SCID mice
Tsuchiya et al. The Development of Colitogenic CD4" T Cells Is Regulated by
HK1227625A1 (en) Genetically modified mice and engraftment
HK1227625B (en) Genetically modified mice and engraftment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130625

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150127

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150501

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20150722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151109